| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf6edae5250129896be5ca2e33a61ed3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d25ca02fb0e96ed0e3eb8df494020f8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d5d546aa6cbfb52c137af7cafc36bf4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2015-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5c252066210d5e33a8480e34f6558ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fed62be95f9c363b258488dd5230eee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8a5cddc9336bf1312481f9f9fc1bc8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c78cd5b5b5889c5b33e84cddefcefc6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a059f8bdabf5ce0f4578aca85e2c3c2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_686c9486acadeabaa9e7fed620a44593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcdc295efa7ff428939b8f83a2fe6977
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_543f961da9877703fe51434592905067 |
| publicationDate |
2015-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015115545-A1 |
| titleOfInvention |
Method for evaluating of metastasis or risk of recurrence of breast cancer |
| abstract |
Provided is a technique for objectively, rapidly and highly accurately evaluating the presence or absence of the effect of a medicine, the risk of recurrence or the possibility of metastasis in a chemical therapy for breast cancer. A method for evaluating the metastasis of breast cancer or the risk of recurrence of breast cancer in a breast cancer patient, said method comprising a step of measuring the level of expression of at least one expression product of DNA containing a transcription initiation domain in a biological sample derived from a cancer tissue separated from the patient. |
| priorityDate |
2014-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |